Myeloprotective Effects of Different Amifostine Regimens in Rabbits Undergoing High-Dose Treatment with 186Rhenium-(tin)1,1- Hydroxyethylidene Diphosphonate (186Re-HEDP)-Reference-Cited by-同舟云学术

Myeloprotective Effects of Different Amifostine Regimens in Rabbits Undergoing High-Dose Treatment with 186Rhenium-(tin)1,1- Hydroxyethylidene Diphosphonate (186Re-HEDP)

Published:2003-12 Issue:6 Volume:18 Page:887-893
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Brenner Winfried¹,Kampen Willm Uwe²,Brümmer Corinna²,von Forstner Corinna²,Zuhayra Maaz²,Muhle Claus²,Czech Norbert²,Henze Eberhard²

Affiliation:

1. Division of Nuclear Medicine, University of Washington Medical Center, Seattle, WA

2. Clinic of Nuclear Medicine, Christian-Albrechts-University, Kiel, Germany

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497803322702851

Reference25 articles.

1. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.

2. Targeted Radiotherapy of Osteosarcoma Using153Sm-Edtmp: A new promising approach

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies;Current Radiopharmaceuticals;2019-10-01

2. Targeted Radionuclide Therapy;Clinical Radiation Oncology;2016

3. Targeted Radionuclide Therapy—Expanded Content;Clinical Radiation Oncology;2012

4. Potential Utility of Radioprotective Agents in the Practice of Nuclear Medicine;Cancer Biotherapy and Radiopharmaceuticals;2009-12

5. Amifostine Use in Radiation-Induced Kidney Damage;Strahlentherapie und Onkologie;2008-07